SCHEMBL1629454

SCHEMBL1629454

CCC(C)OP(=O)(O)c1cc(N)ccc1N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.34
FDPS P14324 1/20 0.32
ALDH1A1 P00352 3/20 0.30
GAA P10253 3/20 0.30
USP2 O75604 3/20 0.30
PKM P14618 2/20 0.30
MEN1 O00255 2/20 0.30
POLB P06746 2/20 0.30
MAPT P10636 2/20 0.30
KMT2A Q03164 2/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
CASP1 P29466 1/20 0.30
HTT P42858 1/20 0.30
CASP7 P55210 1/20 0.30
ATM Q13315 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1631356 0.87 ALOX15 (0.34) ALDH1A1ALOX15HSD17B10TP53THRB
SCHEMBL1629974 0.86 ALDH1A1 (0.36) ALDH1A1MAPTALOX15KDM4ETHRB
SCHEMBL4023643 0.86 DPP8 (0.34) ALDH1A1MEN1POLBMAPTKMT2A
SCHEMBL1631592 0.85 MAPK1 (0.37) ALDH1A1USP2MEN1KMT2AHSD17B10
SCHEMBL1631192 0.82 HTT (0.41) ALDH1A1GAAMEN1POLBMAPT
SCHEMBL641442 0.82 ALDH1A1 (0.35) FDPSALDH1A1MAPTHSD17B10KDM4E
SCHEMBL7501045 0.78 LMNA (0.35) ALOX5FDPSGAATP53TDP1
SCHEMBL1630150 0.78 DPP8 (0.36) ALDH1A1ALOX15HSD17B10TP53THRB
SCHEMBL8922173 0.77 ALDH1A1 (0.38) ALDH1A1POLBKDM4ETP53
SCHEMBL1629969 0.75 HSD17B10 (0.37) ALDH1A1GAAUSP2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183260-B1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV IDENIX PHARMACEUTICALS INC (US) 2011-06-01 EP disclosed
US-7932240-B2 Phosphadiazine HCV polymerase inhibitors IV IDENIX PHARMACEUTICALS, INC. (US) 2011-04-26 US disclosed
US-20090081158-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV IDENIX PHARMACEUTICALS, INC. (US) 2009-03-26 US disclosed
WO-2009032177-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS I AND II IDENIX PHARMACEUTICALS, INC. (US) 2009-03-12 WO disclosed
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed
US-20090060866-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS I AND II IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed
US-20090060872-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS V IDENIX PHARMACEUTICALS, INC. (US) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090081158-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV POLI, ITPA, POLR2H ALOX5 1812/4885FDPS 269/4885ALDH1A1 1722/4885
US-20090060872-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS V POLI, POLR2H, POLR2E ALOX5 927/4885FDPS 215/4885ALDH1A1 2086/4885
US-20090060867-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI POLR2E, POLR2H, POLI ALOX5 1325/4885FDPS 183/4885ALDH1A1 1965/4885
US-20090060866-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS I AND II POLR2E, POLR2H, POLR2A ALOX5 1916/4885FDPS 338/4885ALDH1A1 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.